BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27378136)

  • 1. Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation.
    Tripodi SI; Mazza C; Moratto D; Ramenghi U; Caorsi R; Gattorno M; Badolato R
    Immunol Lett; 2016 Sep; 177():22-4. PubMed ID: 27378136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
    Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
    Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants in CASP10, a diagnostic challenge: Single center experience and review of the literature.
    Matas Pérez E; Valdivieso Shephard JL; Bravo García-Morato M; Robles Marhuenda Á; Martinez-Ojinaga Nodal E; Prieto Bozano G; González Casado I; Salamanca Fresno L; Méndez Echevarria A; Del Rosal Rabes T; Allende Martínez L; López-Granados E; Rodríguez Pena R
    Clin Immunol; 2021 Sep; 230():108812. PubMed ID: 34329798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
    Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
    Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
    Zhu S; Hsu AP; Vacek MM; Zheng L; Schäffer AA; Dale JK; Davis J; Fischer RE; Straus SE; Boruchov D; Saulsbury FT; Lenardo MJ; Puck JM
    Hum Genet; 2006 Apr; 119(3):284-94. PubMed ID: 16446975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases.
    Shiota M; Yang X; Kubokawa M; Morishima T; Tanaka K; Mikami M; Yoshida K; Kikuchi M; Izawa K; Nishikomori R; Okuno Y; Wang X; Sakaguchi H; Muramatsu H; Kojima S; Miyano S; Ogawa S; Takagi M; Hata D; Kanegane H
    J Clin Immunol; 2015 Jul; 35(5):454-8. PubMed ID: 25896945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.
    Tadaki H; Saitsu H; Kanegane H; Miyake N; Imagawa T; Kikuchi M; Hara R; Kaneko U; Kishi T; Miyamae T; Nishimura A; Doi H; Tsurusaki Y; Sakai H; Yokota S; Matsumoto N
    Int J Immunogenet; 2011 Aug; 38(4):287-93. PubMed ID: 21382177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
    Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
    Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
    Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
    Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient.
    Leal-Seabra F; Costa GS; Coelho HP; Oliveira A
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27979843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
    Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
    J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers.
    Roberts CA; Ayers L; Bateman EA; Sadler R; Magerus-Chatinet A; Rieux-Laucat F; Misbah SA; Ferry BL
    Hum Immunol; 2013 Dec; 74(12):1531-5. PubMed ID: 23993982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder.
    Jeffreys SM; Levy RA; Crary SE
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e305-e308. PubMed ID: 28991130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of autoimmune lymphoproliferactive syndrome and literature review].
    Liu L; Hu J; Ma J; Li X; Li F; Li C
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic functions and gene expression profile distinct double-negative cells from single positive cells in the autoimmune lymphoproliferative syndrome.
    Lev A; Simon AJ; Amariglio N; Rechavi G; Somech R
    Autoimmun Rev; 2012 Aug; 11(10):723-30. PubMed ID: 22273982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.